Impact Biomedical IBO Balance Sheet (2022-2026)

NYSE IBO
$0.46 -0.03 (-7.15%)
As of: Sep 10, 2026 · 3:57 PM EDT
Reported Financials

Impact Biomedical Quarterly Balance Sheet

Periods 17 quarters
Latest Jun 2026

Impact Biomedical reported total assets of $0.02B and total liabilities of $0.00B for the quarter ended Jun 2026, down 12.1% year over year. This balance sheet covers 17 quarters of results from Jun 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Cash & Current Investments 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Receivables - NetNet Receivables 0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Receivables - OtherOther Receivables 0.00B0.00B
Receivables 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Finished Goods 0.00B0.00B0.00B0.00B0.00B
Inventory 0.00B0.00B0.00B0.00B0.00B0.00B
Prepaid Assets 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Current Assets 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net) 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Long-Term Investments 0.00B0.00B
Goodwill 0.03B0.03B0.05B0.03B0.03B0.03B0.03B-0.03B
Intangibles 0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B0.02B
Goodwill & Intangibles 0.05B0.05B0.07B0.05B0.05B0.05B0.05B-0.00B0.02B0.02B0.02B0.02B0.02B0.02B
Long-Term Deferred Tax 0.00B
Non-Current Assets 0.05B0.05B0.04B0.04B0.04B0.04B0.04B0.02B0.02B0.02B0.02B0.02B0.02B0.02B
Assets 0.05B0.05B0.05B0.04B0.04B0.04B0.05B0.02B0.02B0.02B0.02B0.02B0.02B0.02B
Liabilities
Current Liabilities
Accounts Payables 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Notes Payables 0.01B0.01B0.01B0.01B0.01B0.01B0.00B0.01B0.01B0.02B0.02B
Payables 0.01B0.01B0.01B0.01B0.01B0.01B0.00B0.01B0.01B0.02B0.02B0.00B0.00B0.00B
Accumulated Expenses 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Accumulated Expenses 0.00B0.00B0.00B0.00B0.00B
Total Current Liabilities 0.01B0.01B0.01B0.01B0.01B0.01B0.00B0.01B0.01B0.02B0.02B0.00B0.00B0.00B
Non-Current Liabilities
Non-Current Debt 0.01B0.01B0.01B0.01B0.02B0.02B
Minority Interest 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.00B0.00B0.00B0.00B0.00B
Total Non-Current Liabilities 0.01B0.02B
Total Liabilities -0.04B-0.04B0.01B-0.03B0.02B0.02B0.02B0.02B0.02B0.01B0.01B0.01B0.03B0.03B0.00B0.00B0.00B
Shareholder's Equity
Total Debt 0.01B0.01B0.01B0.02B0.01B0.01B0.01B0.02B0.02B0.04B0.05B
Common Equity 0.04B0.04B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.03B0.01B0.01B-0.01B-0.01B0.02B0.01B0.01B
Liabilities and Shareholders Equity 0.05B0.05B0.05B0.04B0.04B0.04B0.05B0.02B0.02B0.02B0.02B0.02B0.02B0.02B
Retained Earnings -0.01B-0.01B-0.01B0.04B0.04B0.04B0.04B0.04B0.04B-0.05B-0.05B0.06B0.06B0.06B
Preferred Shares 0.00B0.00B0.00B0.00B60.50B0.00B0.00B0.00B